glutamine has been researched along with Apolipoprotein B-100, Familial Defective in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benn, M; Jensen, G; Jensen, HK; Nordestgaard, BG; Steffensen, R; Tybjaerg-Hansen, A | 1 |
Dempsey, G; Guernsey, DL; Morash, B; Nassar, BA; Tan, MH | 1 |
Keller, C; Rauh, G; Schewe, CK; Schuster, H; Stratmann, G; Wolfram, G; Zöllner, N | 1 |
Kastelein, JJ; Kindt, I; Knipscheer, HC; Mulder, WJ; Nurmohamed, MT; Smalbraak, H; van den Ende, A | 1 |
Fischer, J; Keller, C; Rauh, G; Schuster, H; Wolfram, G; Zöllner, N | 1 |
2 trial(s) available for glutamine and Apolipoprotein B-100, Familial Defective
Article | Year |
---|---|
Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
Topics: Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Arginine; Canada; Electrophoresis, Polyacrylamide Gel; Female; Gene Expression Regulation; Glutamine; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Phenotype; Polymerase Chain Reaction; Receptors, LDL; Restriction Mapping | 1994 |
Magnesium pyridoxal-5'-phosphate glutamate, "A vitamin B6 derivative", does not affect lipoprotein levels in patients with familial hypercholesterolaemia.
Topics: Adult; Anticholesteremic Agents; Double-Blind Method; Female; Glutamine; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Pyridoxal Phosphate | 1997 |
3 other study(ies) available for glutamine and Apolipoprotein B-100, Familial Defective
Article | Year |
---|---|
Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Apolipoproteins B; Arginine; Bias; Cholesterol; Female; Genetic Carrier Screening; Genetics, Population; Glutamine; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Myocardial Ischemia; Phenotype; Receptors, LDL | 2005 |
Independent mutation of arginine(3500)-->glutamine associated with familial defective apolipoprotein B-100.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins B; Arginine; Base Sequence; Female; Genes, Dominant; Genetic Markers; Germany; Glutamine; Haplotypes; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Structure-Activity Relationship | 1993 |
Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.
Topics: Adolescent; Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Arginine; Base Sequence; Child; DNA, Circular; Female; Glutamine; Heterozygote; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Protein Binding | 1991 |